Guangzhou Blood Center
13
0
0
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
11%
1 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Blood Donation and Subjective Well-being
Role: lead
RhD+ Blood Transfusion to Asian-type DEL Recipients
Role: lead
Effect of Different Liquids Intake in Vasovagal Reaction After Whole Blood Donation
Role: lead
Message Framing on Recruiting Rh-D Negative Blood Donors
Role: lead
Recruit Blood Donors Via SMS During Epidemic of COVID-19 #Second Repeat Trial#
Role: lead
Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial）
Role: lead
Recruit Blood Donors Via SMS During Epidemic of COVID-19
Role: lead
The Effect of Message Framing on Blood Donation-Study 1
Role: lead
Blood Donor Recruitment During Epidemic of COVID-19
Role: lead
The Effect of Recruiting Inactive Blood Donors Using Different Means
Role: lead
The Effect of Message Framing on Blood Donation-Study 2
Role: lead
Reactivation of Inactive Blood Donors
Role: lead
The Effective Ways of Recruiting Lapsed Blood Donors: a Stratified Randomized Pilot Study
Role: lead
All 13 trials loaded